IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acasti Pharma Inc

CUSIP: 004390104 | 1 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Raelipskie Partnership2
0.0% of portfolio›$5
StyleTurnoverLocationFiled
Raelipskie Partnership
2$50.0%CoreLowWaterloo, Australia2026-08-04